Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ureteral Neoplasms × Sorafenib × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 49 Carcinoma, Renal Cell 23 Liver Neoplasms 22 Neoplasms 18 Breast Neoplasms 15 Carcinoma, Non-Small-Cell Lung 14 Kidney Neoplasms 10 Leukemia, Myeloid, Acute 9 Melanoma 8 Sarcoma 7 Prostatic Neoplasms 7 Neoplasm Metastasis 6 Lung Neoplasms 6 Glioblastoma 6 Ovarian Neoplasms 5 Brain Neoplasms 5 Thyroid Neoplasms 4 Recurrence 4 Pancreatic Neoplasms 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leiomyosarcoma 3 Gliosarcoma 3 Gallbladder Neoplasms 3 Carcinoma 3

Interventions

Gemcitabine 5 Cisplatin 4 enfortumab vedotin 2 Ramucirumab 2 Platinum 2 Docetaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 vinflunine 1 rucaparib 1 pembrolizumab 1 eribulin 1 enzalutamide 1 dehydroftorafur 1 carotuximab 1 avelumab 1 atezolizumab 1 Standard of Care 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1 Mitozytrex 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Interleukin-7 1 Immunoglobulin G 1 Icrucumab 1 IMC-18F1 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡